The development of orally inhaled and nasal drug products (OINDPs) presents unique challenges due to the complexity of drug delivery to the respiratory system. Early-stage ergonomic studies are crucial for ensuring product success, as they help optimize the usability and effectiveness of the delivery devices, enhance patient compliance, and streamline regulatory approval processes.

This presentation explores the importance of conducting ergonomic studies early in the development of OINDPs, supported by data and insights from industry experts.

Watch our audio presentation to discover:

• How ergonomic studies impact reliable drug dosing, helping ensure safe and effective treatment every time
• How the Ergo workflow is designed to accommodate a wide range of patient demographics
• The data that drives better product design, enabling more user-friendly devices and improved patient outcomes

Access This Content